KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In Process
Ratios

CRISPR Therapeutics AG (CRSP) Long-Term Debt Issuances (2016)

CRISPR Therapeutics AG's Long-Term Debt Issuances history spans 1 years, with the latest figure at $10000.0 for Q4 2016.

  • For Q4 2016, Long-Term Debt Issuances changed N/A year-over-year to $10000.0; the TTM value through Dec 2016 reached $35.0 million, changed N/A, while the annual FY2016 figure was $35.0 million, 8.44% down from the prior year.
  • Long-Term Debt Issuances for Q4 2016 was $10000.0 at CRISPR Therapeutics AG, down from $35.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $35.0 million in Q1 2016 and bottomed at $10000.0 in Q4 2016.